Clarient Inc announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published.
Read MoreGeorgia-Battelle Principal Research Scientist Roy Johnson was part of a team that was awarded the Association of Public Health Laboratories (APHL) Presidential Award for contributions during the influenza H1N1 pandemic response.
Read MoreHealth Diagnostic Laboratory Adds CYP2C19 Genetic Testing Health Diagnostic Laboratory Inc announced its new capability to run the CYP2C19 genetic test. HDL Inc, headquartered in the Virginia Biotechnology Research Park, has added CYP2C19 to its
Read MoreGold Standard Diagnostics Inc (GSD) announced the execution of an agreement with Axis-Shield to distribute their proprietary assays in the US Market.
Read More
From sample collection to splash protection, safety remains a key concern.
Read More